Aurora Cannabis (NYSE:ACB) Price Target Cut to $15.00 by Analysts at CIBC


Share on StockTwits

Aurora Cannabis (NYSE:ACB) had its target price trimmed by CIBC from $18.50 to $15.00 in a research report sent to investors on Monday morning, The Fly reports. The brokerage currently has a neutral rating on the stock.

Several other brokerages also recently commented on ACB. BMO Capital Markets downgraded shares of Aurora Cannabis from a market perform rating to an underperform rating and set a $9.00 price objective on the stock. in a research report on Thursday, December 17th. Jefferies Financial Group reissued an underperform rating and set a $4.59 price target on shares of Aurora Cannabis in a research report on Monday, January 4th. Cantor Fitzgerald boosted their price objective on shares of Aurora Cannabis from $17.00 to $18.00 and gave the stock a neutral rating in a report on Friday, February 12th. Needham & Company LLC cut Aurora Cannabis from a hold rating to an underperform rating in a research note on Friday, February 12th. Finally, Desjardins lowered Aurora Cannabis from a hold rating to a sell rating in a research report on Friday, February 12th. Seven investment analysts have rated the stock with a sell rating and nine have issued a hold rating to the company. The stock has a consensus rating of Hold and an average target price of $11.18.

NYSE:ACB opened at $8.42 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.88 and a quick ratio of 1.07. The company’s 50-day simple moving average is $10.31 and its 200 day simple moving average is $8.97. Aurora Cannabis has a one year low of $3.71 and a one year high of $19.68. The firm has a market capitalization of $1.67 billion, a P/E ratio of -0.34 and a beta of 3.44.

Aurora Cannabis (NYSE:ACB) last announced its quarterly earnings data on Thursday, February 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.09). Aurora Cannabis had a negative net margin of 1,238.94% and a negative return on equity of 16.32%. The company had revenue of $51.93 million for the quarter, compared to analysts’ expectations of $54.66 million. On average, equities research analysts expect that Aurora Cannabis will post -1.17 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Mackenzie Financial Corp raised its holdings in shares of Aurora Cannabis by 5.4% in the fourth quarter. Mackenzie Financial Corp now owns 13,621 shares of the company’s stock worth $113,000 after buying an additional 700 shares during the period. US Bancorp DE raised its holdings in shares of Aurora Cannabis by 23.0% in the fourth quarter. US Bancorp DE now owns 6,018 shares of the company’s stock worth $50,000 after buying an additional 1,125 shares during the period. Advisory Services Network LLC raised its holdings in shares of Aurora Cannabis by 87.6% in the fourth quarter. Advisory Services Network LLC now owns 3,005 shares of the company’s stock worth $25,000 after buying an additional 1,403 shares during the period. Tradewinds Capital Management LLC raised its holdings in shares of Aurora Cannabis by 38.8% in the fourth quarter. Tradewinds Capital Management LLC now owns 5,045 shares of the company’s stock worth $42,000 after buying an additional 1,409 shares during the period. Finally, Wells Fargo & Company MN raised its holdings in shares of Aurora Cannabis by 32.5% in the fourth quarter. Wells Fargo & Company MN now owns 5,917 shares of the company’s stock worth $49,000 after buying an additional 1,453 shares during the period. Hedge funds and other institutional investors own 11.86% of the company’s stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: What are the benefits of a portfolio tracker?

The Fly

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.